CH529155A - Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen - Google Patents

Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen

Info

Publication number
CH529155A
CH529155A CH390069A CH390069A CH529155A CH 529155 A CH529155 A CH 529155A CH 390069 A CH390069 A CH 390069A CH 390069 A CH390069 A CH 390069A CH 529155 A CH529155 A CH 529155A
Authority
CH
Switzerland
Prior art keywords
virostatically
carbolines
preparation
effective new
effective
Prior art date
Application number
CH390069A
Other languages
English (en)
Inventor
Elks Joseph
Basil Webb Godfrey
Ian Gregory Gordon
Derek Cocker John
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Priority to CH962672A priority Critical patent/CH530409A/de
Publication of CH529155A publication Critical patent/CH529155A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH390069A 1968-03-15 1969-03-14 Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen CH529155A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH962672A CH530409A (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1273268A GB1268773A (en) 1968-03-15 1968-03-15 NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
CH529155A true CH529155A (de) 1972-10-15

Family

ID=10010080

Family Applications (1)

Application Number Title Priority Date Filing Date
CH390069A CH529155A (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen

Country Status (9)

Country Link
AT (2) AT305277B (de)
BE (1) BE729854A (de)
CH (1) CH529155A (de)
DE (1) DE1913124A1 (de)
FR (1) FR2004000A1 (de)
GB (1) GB1268773A (de)
IE (1) IE32706B1 (de)
NL (1) NL6903974A (de)
SE (1) SE370399B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600651D0 (en) * 1986-01-11 1986-02-19 Beecham Group Plc Compounds
US4952584A (en) * 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
US6147085A (en) * 1999-04-01 2000-11-14 Neurogen Corporation Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
GEP20135728B (en) 2006-10-09 2013-01-25 Takeda Pharmaceuticals Co Kinase inhibitors
EP2161271A1 (de) 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Alpha-Carbolin-Hemmer von NMP-ALK, RET und Bcr-Abl
WO2016037106A1 (en) * 2014-09-05 2016-03-10 Allosteros Therapeutics, Inc CaMKII INHIBITORS AND USES THEREOF

Also Published As

Publication number Publication date
FR2004000A1 (de) 1969-11-14
BE729854A (de) 1969-09-15
AT306713B (de) 1973-04-25
AT305277B (de) 1973-02-26
SE370399B (de) 1974-10-14
NL6903974A (de) 1969-09-17
GB1268773A (en) 1972-03-29
IE32706B1 (en) 1973-10-31
IE32706L (en) 1969-09-15
DE1913124A1 (de) 1969-10-02

Similar Documents

Publication Publication Date Title
AT301765B (de) Verfahren zur Herstellung von neuem 2-Brom-α-ergokryptin
AT283353B (de) Verfahren zur Herstellung von neuen N-Tritylimidazolderivaten
CH523269A (de) Verfahren zur Herstellung von neuen Imidazolidinochinazolinderivaten
AT291260B (de) Verfahren zur Herstellung von neuen 1-Hydroxy-2-pyridonen
AT291450B (de) Verfahren zur Herstellung neuen 16α-Hydroxy-17α-aminosteroiden
AT301021B (de) Verfahren zur Herstellung des neuen Erythromycylamins
AT303003B (de) Verfahren zur Herstellung von neuen N-Carbonylflouralkylsulfonaniliden
AT286284B (de) Verfahren zur Herstellung von neuen 7-Cyan-cumarinderivaten
CH529155A (de) Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen
AT298479B (de) Verfahren zur Herstellung von neuen Thiophen-3-isonitrilen
AT293358B (de) Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten
AT291446B (de) Verfahren zur Herstellung von neuen Apovincaminsäureamiden
CH505829A (de) Verfahren zur Herstellung von neuen Derivaten des p-Aminoalkylbenzolsulfonamids
AT303017B (de) Verfahren zur Herstellung von neuen Tetraisocyanaten
AT299213B (de) Verfahren zur Herstellung von neuen 2-(Dioxo-piperazino)-benzophenonen
AT300780B (de) Verfahren zur Herstellung von neuen Dihalogenalkylphthalimiden
CH513110A (de) Verfahren zur Herstellung von neuen Bis-alkanolamin-Derivaten
AT306712B (de) Verfahren zur Herstellung von neuen 1-Phenyl-3-äthoxy-1H-isoindolen
AT293424B (de) Verfahren zur Herstellung von neuen N-Carbonylfluorsulfonaniliden
AT284145B (de) Verfahren zur Herstellung von neuen 3-Aryl-5-methylhydantoinen
AT308729B (de) Verfahren zur Herstellung von neuen subtituierten Phenalkylaminen
AT292013B (de) Verfahren zur Herstellung von neuen basisch substituierten 1-Cyano-O-carbamoyl-formoximen
CH536848A (de) Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen
AT287687B (de) Verfahren zur Herstellung von neuen 7-Triazinyl-cumarinen
AT294829B (de) Verfahren zur Herstellung von neuen 2-Acyl-2-thiazolinen

Legal Events

Date Code Title Description
PL Patent ceased